首页> 外文会议>Biophotonics and immune responses VIII >In vivo flow cytometry visualizes the effects of tumor resection on metastasis by real-time monitoring of rare circulating cancer cells
【24h】

In vivo flow cytometry visualizes the effects of tumor resection on metastasis by real-time monitoring of rare circulating cancer cells

机译:体内流式细胞术通过实时监测稀有循环癌细胞来可视化肿瘤切除术对转移的影响

获取原文
获取原文并翻译 | 示例

摘要

Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world, with approximately 1,000,000 cases reported every year. The fate of circulating tumor cells (CTCs) is an important determinant of metastasis and recurrence, which lead to most deaths in HCC. Therefore, quantification of CTCs proves to be an emerging tool for diagnosing, stratifying and monitoring patients with metastatic diseases. In vivo flow cytometry (IVFC) has the capability to monitor the dynamics of fluorescently labeled CTCs continuously and non-invasively. Here, we combine IVFC technique and a GFP-transfected HCC orthotopic metastatic tumor model to monitor CTC dynamics. Our IVFC has ~1.8-fold higher sensitivity than whole blood analysis by conventional flow cytometry. We find out a significant difference of CTC dynamics between orthotopic and subcutaneous (s.c.) tumor models. We also investigate whether liver resection promotes or restricts hematogenous metastasis in advanced HCC. Our result shows that the number of CTCs and early metastases decreases after the resection. CTC dynamics is correlated with tumor growth in our orthotopic tumor model. The number and size of distant metastases correspond to CTC dynamics. The novel IVFC technique combined with orthotopic tumor models might provide insights to tumor hematogenous metastasis and guidance to cancer therapy.
机译:肝细胞癌(HCC)是世界上最常见的恶性肿瘤之一,每年报告约1,000,000例病例。循环肿瘤细胞(CTC)的命运是转移和复发的重要决定因素,而转移和复发会导致大多数HCC死亡。因此,CTC的定量被证明是诊断,分层和监测转移性疾病患者的新兴工具。体内流式细胞术(IVFC)具有连续且无创地监测荧光标记CTC动力学的能力。在这里,我们结合IVFC技术和GFP转染的HCC原位转移性肿瘤模型来监测CTC动态。我们的IVFC的灵敏度是传统流式细胞仪的全血分析的约1.8倍。我们发现原位和皮下(s.c.)肿瘤模型之间CTC动态的显着差异。我们还调查了肝脏切除术是否能促进或限制晚期HCC的血源性转移。我们的结果显示,切除后CTC和早期转移的数量减少。在我们的原位肿瘤模型中,CTC动态与肿瘤生长相关。远处转移的数量和大小对应于CTC动态。新颖的IVFC技术与原位肿瘤模型相结合可能会为肿瘤的血源性转移提供指导,并为癌症治疗提供指导。

著录项

  • 来源
    《Biophotonics and immune responses VIII》|2013年|85820F.1-85820F.8|共8页
  • 会议地点 San Francisco CA(US)
  • 作者单位

    Med-X Research Institute and School of Biomedical Engineering, Shanghai Jiao Tong University, 1940 Huashan Road, Shanghai 200240, China;

    Department of Chemistry, Fudan University, 220 Handan Road, Shanghai 200434, China,Institutes of Biomedical Sciences, Fudan University, 138 Yi Xue Yuan Road, Shanghai 200032, China;

    Department of Radiology, University of Michigan, Ann Arbor, Michigan 48109, USA;

    Med-X Research Institute and School of Biomedical Engineering, Shanghai Jiao Tong University, 1940 Huashan Road, Shanghai 200240, China,Department of Chemistry, Fudan University, 220 Handan Road, Shanghai 200434, China,Institutes of Biomedical Sciences, Fudan University, 138 Yi Xue Yuan Road, Shanghai 200032, China;

  • 会议组织
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    In vivo flow cytometry; circulating cancer cells; real-time monitoring; tumor resection; orthotopic tumor model; hepatocellular carcinoma; confocal imaging;

    机译:体内流式细胞仪;循环癌细胞;实时监控;肿瘤切除原位肿瘤模型肝细胞癌;共聚焦成像;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号